Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms

P.R. Mutwa; Q. Fillekes; M. Malgaz; D. Tuyishimire; R. van de Kraats; K.R. Boer; D.M. Burger; R.H. van Schaik; N. Muganga; S.P.M. Geelen

doi:10.1097/QAI.0b013e3182569f57

Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms

P.R. Mutwa
, Q. Fillekes
, M. Malgaz
, D. Tuyishimire
, R. van de Kraats
, K.R. Boer
, D.M. Burger
, R.H. van Schaik
, N. Muganga
, S.P.M. Geelen

Infectious Diseases

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	400-404
Number of pages	5
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	60
Issue number	4
DOIs	https://doi.org/10.1097/QAI.0b013e3182569f57
Publication status	Published - 2012

Access to Document

10.1097/QAI.0b013e3182569f57

http://www.ncbi.nlm.nih.gov/pubmed/22481606

Cite this

Mutwa, P. R., Fillekes, Q., Malgaz, M., Tuyishimire, D., van de Kraats, R., Boer, K. R., Burger, D. M., van Schaik, R. H., Muganga, N., & Geelen, S. P. M. (2012). Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms. Journal of Acquired Immune Deficiency Syndromes, 60(4), 400-404. https://doi.org/10.1097/QAI.0b013e3182569f57

@article{09861a9a0da240aa9fd8579e536d2bf7,

title = "Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms",

author = "P.R. Mutwa and Q. Fillekes and M. Malgaz and D. Tuyishimire and \{van de Kraats\}, R. and K.R. Boer and D.M. Burger and \{van Schaik\}, R.H. and N. Muganga and S.P.M. Geelen",

year = "2012",

doi = "10.1097/QAI.0b013e3182569f57",

language = "English",

volume = "60",

pages = "400--404",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Wolters Kluwer Health",

number = "4",

}

Mutwa, PR, Fillekes, Q, Malgaz, M, Tuyishimire, D, van de Kraats, R, Boer, KR, Burger, DM, van Schaik, RH, Muganga, N & Geelen, SPM 2012, 'Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms', Journal of Acquired Immune Deficiency Syndromes, vol. 60, no. 4, pp. 400-404. https://doi.org/10.1097/QAI.0b013e3182569f57

Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms. / Mutwa, P.R.; Fillekes, Q.; Malgaz, M. et al.
In: Journal of Acquired Immune Deficiency Syndromes, Vol. 60, No. 4, 2012, p. 400-404.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms

AU - Mutwa, P.R.

AU - Fillekes, Q.

AU - Malgaz, M.

AU - Tuyishimire, D.

AU - van de Kraats, R.

AU - Boer, K.R.

AU - Burger, D.M.

AU - van Schaik, R.H.

AU - Muganga, N.

AU - Geelen, S.P.M.

PY - 2012

Y1 - 2012

U2 - 10.1097/QAI.0b013e3182569f57

DO - 10.1097/QAI.0b013e3182569f57

M3 - Article

C2 - 22481606

SN - 1525-4135

VL - 60

SP - 400

EP - 404

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 4

ER -